In clinical trials, patients using Semaglutide lost an average of 15% of their body weight, with some experiencing even greater reductions
Supporting your microbiome can help reinforce those signals and may make the overall experience feel smoother and more sustainable
For example, Blue Cross Blue Shield of Illinois and Blue Cross Complete of Michigan do list Mounjaro as a non-preferred drug but require prior authorization
Burman P, Ritzen EM, Lindgren AC
There is a loss of time for patient care and a huge increase in time burden outside the visit for doctors and pharmacists. Another major insurance change coming next year will affect another large swath of Dushays patients: In January, BCBS Massachusetts will be excluding all GLP-1s from coverage for treatment of obesity, reserving coverage for these drugs only when indicated to treat type 2 diabetes
And as of now, Medicare may make eligible about 3 million patients which have both heart disease and obesity for Wegovy